ArthNow Logo
ArthNow
•2 min read•
✦Reported by Reuters

SEC's Daly sees no chance of launching 3x, 5x single-stock leveraged ETFs

SEC's Daly sees no chance of launching 3x, 5x single-stock leveraged ETFs
Source: Reuters

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓The US Securities and Exchange Commission is unlikely to approve ETFs offering three to five times leverage on individual stocks.
  • ✓Brian Daly said, "The law says 2x; we are stopping at 2x." While many issuers filed applications, the agency maintains that current rules limit leverage to double the performance.

Story at a Glance

Category
Indian Markets
Reported By
Reuters
Reading Speed
2 Minute(s)
Market Focus
India Economy

NEW YORK, Nov 19 (Reuters) - The US Securities and Exchange Commission is unlikely to approve exchange-traded funds that offer leverage of three to five ​times the exposure to the daily performance of individual stocks, according ‌to Brian Daly, director of the agency's division of investment management.

While several issuers have pending SEC applications for such products, Daly told a Bloomberg conference on Thursday that the ​law clearly limits leverage on such ETF products to double the ​performance of the single underlying stock.

Sign up here.

"For us, that's more or ⁠less where the discussion ends," Daly said. "The law says 2x; we are ​stopping at 2x."

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Reuters

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.